Banks P M
Department of Pathology, University of Texas Health Science Center, San Antonio 78284-7750.
Cancer Res. 1992 Oct 1;52(19 Suppl):5453s-5455s.
The question is raised as to whether changes in criteria for the diagnosis of non-Hodgkin's lymphomas, both clinical and pathological, have changed over the past four decades in sufficient scale to create a spurious increase in the apparent incidence of this grouping of disease. In the decade of the 1970s refinement in histomorphological criteria for the diagnosis of Hodgkin's disease resulted in as many as 10-15% of cases which previously would have been diagnosed as Hodgkin's disease being diagnosed instead as non-Hodgkin's lymphoma. Other considerations, including distinction of non-Hodgkin's lymphomas from leukemias and plasma cell myelomas, and recent recognition of angioimmunoblastic lymphadenopathy and extranodal "pseudolymphomas" as variant forms of non-Hodgkin's lymphoma, appear to have added only marginally to the total of reported cases. It is concluded that the increase in reported incidence of non-Hodgkin's lymphoma cannot be explained on the basis of changes in diagnostic criteria.
问题在于,在过去四十年里,非霍奇金淋巴瘤的临床和病理诊断标准的变化幅度是否足以导致该组疾病的表观发病率出现虚假增长。在20世纪70年代,霍奇金病组织形态学诊断标准的细化导致多达10%至15%以前会被诊断为霍奇金病的病例被重新诊断为非霍奇金淋巴瘤。其他因素,包括非霍奇金淋巴瘤与白血病和浆细胞骨髓瘤的区分,以及最近将血管免疫母细胞性淋巴结病和结外“假性淋巴瘤”识别为非霍奇金淋巴瘤的变异形式,似乎仅使报告病例总数略有增加。得出的结论是,非霍奇金淋巴瘤报告发病率的增加不能用诊断标准的变化来解释。